East Greenbush, NY, United States of America

Nilsen Miller

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nilsen Miller. Retrieved from https://idiyas.com/inventor/nilsen-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nilsen Miller: Innovator in Ocular Treatment

Introduction

Nilsen Miller is a notable inventor based in East Greenbush, NY (US). He has made significant contributions to the field of ocular treatment through his innovative methods. His work focuses on improving patient outcomes in eye care.

Latest Patents

Nilsen Miller holds a patent for "Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation." This patent outlines a method of treating an eye disorder in a patient by administering a medicament with a prefilled syringe. The approach is designed to treat the eye disorder while decreasing the likelihood of an ocular infection.

Career Highlights

Miller is currently associated with Regeneron Pharmaceuticals, Inc., where he applies his expertise in developing advanced medical solutions. His work at Regeneron has positioned him as a key player in the pharmaceutical industry, particularly in the realm of ocular health.

Collaborations

One of his notable coworkers is Trevor Langley, with whom he collaborates on various projects aimed at enhancing treatment methodologies.

Conclusion

Nilsen Miller's contributions to ocular treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field of eye health and showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…